Literature DB >> 23964098

Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.

Inge Stegeman1, Thomas R de Wijkerslooth, Esther M Stoop, Monique E van Leerdam, Evelien Dekker, Marjolein van Ballegooijen, Ernst J Kuipers, Paul Fockens, Roderik A Kraaijenhagen, Patrick M Bossuyt.   

Abstract

OBJECTIVE: Faecal immunochemical testing (FIT) is increasingly used in colorectal cancer (CRC) screening but has a less than perfect sensitivity. Combining risk stratification, based on established risk factors for advanced neoplasia, with the FIT result for allocating screenees to colonoscopy could increase the sensitivity and diagnostic yield of FIT-based screening. We explored the use of a risk prediction model in CRC screening.
DESIGN: We collected data in the colonoscopy arm of the Colonoscopy or Colonography for Screening study, a multicentre screening trial. For this study 6600 randomly selected, asymptomatic men and women between 50 years and 75 years of age were invited to undergo colonoscopy. Screening participants were asked for one sample FIT (OC-sensor) and to complete a risk questionnaire prior to colonoscopy. Based on the questionnaire data and the FIT results, we developed a multivariable risk model with the following factors: total calcium intake, family history, age and FIT result. We evaluated goodness-of-fit, calibration and discrimination, and compared it with a model based on primary screening with FIT only.
RESULTS: Of the 1426 screening participants, 1112 (78%) completed the questionnaire and FIT. Of these, 101 (9.1%) had advanced neoplasia. The risk based model significantly increased the goodness-of-fit compared with a model based on FIT only (p<0.001). Discrimination improved significantly with the risk-based model (area under the receiver operating characteristic (ROC) curve: from 0.69 to 0.76, (p=0.02)). Calibration was good (Hosmer-Lemeshow test; p=0.94). By offering colonoscopy to the 102 patients at highest risk, rather than to the 102 cases with a FIT result >50 ng/mL, 5 more cases of advanced neoplasia would be detected (net reclassification improvement 0.054, p=0.073).
CONCLUSIONS: Adding risk based stratification increases the accuracy FIT-based CRC screening and could be used in preselection for colonoscopy in CRC screening programmes.

Entities:  

Keywords:  Cancer Epidemiology; Cancer Prevention; Colorectal Cancer; Screening

Mesh:

Year:  2013        PMID: 23964098     DOI: 10.1136/gutjnl-2013-305013

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

Review 1.  Body mass index and colon cancer screening: the road ahead.

Authors:  Kanwarpreet Tandon; Mohamad Imam; Bahaa Eldeen Senousy Ismail; Fernando Castro
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 2.  Faecal occult blood testing for colorectal cancer screening: the past or the future.

Authors:  Sally C Benton; Helen E Seaman; Stephen P Halloran
Journal:  Curr Gastroenterol Rep       Date:  2015-02

3.  Learning to be More Positive About FIT.

Authors:  Douglas J Robertson
Journal:  Am J Gastroenterol       Date:  2018-11-05       Impact factor: 10.864

4.  Where does it FIT? The roles of fecal testing and colonoscopy in colorectal cancer screening.

Authors:  Grace Clarke Hillyer; Alfred I Neugut
Journal:  Cancer       Date:  2015-05-20       Impact factor: 6.860

5.  Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study.

Authors:  James Turvill; Assad Aghahoseini; Nala Sivarajasingham; Kazim Abbas; Murtaza Choudhry; Kostantinos Polyzois; Kostantinos Lasithiotakis; Dimitra Volanaki; Baek Kim; Fiona Langlands; Helen Andrew; Jesper Roos; Samantha Mellen; Daniel Turnock; Alison Jones
Journal:  Br J Gen Pract       Date:  2016-06-06       Impact factor: 5.386

6.  Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.

Authors:  Clasine M de Klerk; Lisanne M Vendrig; Patrick M Bossuyt; Evelien Dekker
Journal:  Am J Gastroenterol       Date:  2018-08-29       Impact factor: 10.864

7.  Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia.

Authors:  Markus D Knudsen; Thomas de Lange; Edoardo Botteri; Dung-Hong Nguyen; Helge Evensen; Chloé B Steen; Geir Hoff; Tomm Bernklev; Anette Hjartåker; Paula Berstad
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 8.  Risk Prediction Models for Colorectal Cancer: A Systematic Review.

Authors:  Juliet A Usher-Smith; Fiona M Walter; Jon D Emery; Aung K Win; Simon J Griffin
Journal:  Cancer Prev Res (Phila)       Date:  2015-10-13

9.  Assessing Individual Risk for High-Risk Early Colorectal Neoplasm for Pre-Selection of Screening in Shanghai, China: A Population-Based Nested Case-Control Study.

Authors:  Jie Shen; Yiling Wu; Xiaoshuang Feng; Fei Liang; Miao Mo; Binxin Cai; Changming Zhou; Zezhou Wang; Meiying Zhu; Guoxiang Cai; Ying Zheng
Journal:  Cancer Manag Res       Date:  2021-05-12       Impact factor: 3.989

10.  Microbiome Analysis of More Than 2,000 NHS Bowel Cancer Screening Programme Samples Shows the Potential to Improve Screening Accuracy.

Authors:  Caroline Young; Henry M Wood; Alba Fuentes Balaguer; Daniel Bottomley; Niall Gallop; Lyndsay Wilkinson; Sally C Benton; Martin Brealey; Cerin John; Carole Burtonwood; Kelsey N Thompson; Yan Yan; Jennifer H Barrett; Eva J A Morris; Curtis Huttenhower; Philip Quirke
Journal:  Clin Cancer Res       Date:  2021-03-03       Impact factor: 13.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.